No Data
CareNet---Announcing the status of treasury stock acquisition.
Carenet <2150> announced on the 2nd that it disclosed the status of the acquisition of treasury stock based on the provisions of Article 156 of the Companies Act, as reinterpreted and applied in accordance with Article 165, paragraph 3 of the same Act, decided on August 13, 2024. The company acquired 292,200 shares of its common stock through a market buyback on the Tokyo Stock Exchange from September 1 to September 30, with a total acquisition price of 0.186 billion yen. As of September 30, 2024, the total number of shares acquired.
Macromill Research Memo (2): Providing data-driven solutions with diverse acquisition data and a wealth of experience (1)
■MacroMill <3978> Business Overview 1. Business Segments and Service Description Report Segments consist of "japan business" and "south korea business", with the japan business divided into three areas. The characteristics of each area are as follows. (1) Japan Business (fiscal year ending June 2024 sales performance of 37.7 billion yen, revenue composition ratio of 86%) - Focus areas (fiscal year ending June 2024 sales performance of 14.8 billion yen, revenue composition ratio of 34%) Providing online and digital research as core businesses. The gross margin is about 60%.
List of Conversion Stocks (Part 1) [List of Parabolic Signal Conversion Stocks]
○ Buy Conversion Stock List Market Code Company Name Closing Price SAR Tokyo main board <1813> Fudo Tetra 2328 2193<1961> Sanki Kogyo 2406 2155<1964> Chugai Ro 2765 2515<2150> Kea Net 637 604<2374> Scent Care HD 773
CareNet---Completion of payment for disposal of treasury stock as stock compensation with transfer restrictions.
CareNet <2150> announced that the payment procedure for the disposal of treasury stock as restricted stock compensation resolved at the board of directors meeting held on August 13, 2024, has been completed. The number of shares to be disposed of is 419,200 shares of the company's common stock. The disposal price is 595 yen per share, totaling 249,424,000 yen. The recipients of the disposal are three directors of the company (excluding external directors).
Carenet Health Redefines "The Business of Healthcare"
CareNet Research Memo (8): In addition to stable growth of existing services, new growth acceleration is expected through the development of new services.
■Carenet <2150> Outlook for the Future 3. Our company's view Over the two-year period from 2022 to 2023, the pharmaceutical industry has been actively implementing process reforms, and peripheral companies in the pharmaceutical industry, including our company, have emphasized the importance of appropriately responding to industry trends. The impact of e-promotion on revenue has been thoroughly examined through statistical surveys such as ROMI tests, and the company's services have achieved returns that exceed the investment cost. In MR, sales are conducted through face-to-face interactions.
No Data
No Data